Simavita Releases Materials for 2015 Annual General and Special Meeting

SYDNEY, AUSTRALIA--(Marketwired - Nov. 13, 2015) - Simavita Limited (ASX:SVA)(TSX VENTURE:SV) ("Simavita" or the "Company") is pleased to release the materials for its 2015 Annual General and Special Meeting (the "Meeting").

It is anticipated that copies of the Notice, Management Information Circular, proxy forms and voting instruction forms (collectively, the "Meeting Materials") will be mailed to all security holders by no later than Tuesday, November 17, 2015. The Meeting Materials are also available on SEDAR and on the Company's website at www.simavita.com.

As detailed in the attached Notice, the Meeting will be held at 10.00 am (Australian Eastern Daylight Time) on Tuesday, December 15, 2015 at the following address:

This is an important meeting for Simavita and we encourage all shareholders to vote their proxy and voting instruction forms that they will receive shortly in the mail.

For further information, please visit the Company's profile on SEDAR (www.sedar.com) or the Company's website (www.simavita.com).

About Simavita

Simavita is a digital healthcare company that has developed an innovative software platform. The first application for the platform is a world first solution for the management of urinary incontinence, with a focus on the elderly. This platform technology is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.

About SIM™

SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit www.simavita.com.

The TSX Venture Exchange ("TSX-V") has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither the TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this Release.